1. U.S. Department of Health & Human Services National Center for Advancing Translational Sciences. Genetic and Rare Diseases Information Center FAQs about rare diseases. 2010. https://rarediseases.info.nih.gov/diseases/pages/31/faqs-about-rare-diseases.
2. Nguengang Wakap S, Lambert DM, Olry A, Rodwell C, Gueydan C, Lanneau V, et al. Estimating cumulative point prevalence of rare diseases: analysis of the Orphanet database. Eur J Hum Genet. 2020;28:165–73.
3. EURORDIS. European Organization for Rare Diseases. Rare diseases: understanding this public health priority. European Organization for Rare Diseases Website; 2005.
4. Statement on sarcoidosis. Joint statement of the American Thoracic Society (ATS), the European Respiratory Society (ERS) and the World Association of Sarcoidosis and Other Granulomatous Disorders (WASOG) adopted by the ATS Board of Directors and by the ERS Executive Committee, February 1999. Am J Respir Crit Care Med. 1999;160(2):736–55.
5. Spagnolo P, Cullinan P, du Bois RM. Sarcoidosis. In: King Jr TE, Schwarz MI, editors. Interstitial lung disease. Shelton, CT: People’s Medical Publishing House-USA; 2011. p. 433–97.